AlloVir Gains PRIME Status For Anti-Virus T-Cell Therapy

Led By Ex-Alexion CEO David Hallal

 
• By Andrew McConaghie

Joining the ElevateBio stable last May, the company has now gained priority status in the US and Europe for its novel therapy for viral infections in stem cell transplant patients.

EMA_Amsterdam
The European Medicines Agency, now located in Amsterdam • Source: EMA

More from Anti-infective

More from Therapy Areas